Investor search results
240 investors found
🌍 United States📊 early stage🏷 Biopharma
Popular searches

Caroline Farah Lembck, MBA, PhD (abd)
American Businesswoman, Investor & Entrepreneur Founder of LemVega Capital®, Puerto Rico’s leading investment firm going global | Featured NasDaq, Forbes | BA at 19 years old | MBA at 20 | PhD started at 20 | CEO at 21
6
in Biopharma

Kiersten Stead
Managing Partner DCVC Bio: Scientist-investor in early staged deep tech life sciences
3
in Biopharma
Frequently asked questions about Biopharma investors in United States
How many Biopharma early-stage investors are there in United States?
Gritt tracks 240 Biopharma early-stage investors in United States, of which 183 (76%) have a direct email address available.
How can I contact Biopharma investors in United States?
Gritt provides direct email addresses for 76% of investors in this list. On a paid plan you can unlock them and export the list, or use Gritt AI outreach to draft personalised emails that you approve, or let Gritt approve, and send from your Gmail.
Are these investors actively investing in United States startups?
Gritt lists them most active first, by the number of deals they have made in Biopharma, and each profile shows those deals and their dates. To see only investors who have invested recently, use the Last active filter.
Can I filter by investment stage or industry?
Yes — use the filters on the left to narrow by investment stage (early, mid, late) or industry. You can also filter by last active date to focus on investors who have made deals recently.
Can I export this list of Biopharma investors in United States?
Yes — paid Gritt accounts can export any filtered investor list as a CSV, including names, email addresses, LinkedIn profiles and investment counts.
Contact all 240 Biopharma early-stage investors
Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, or let Gritt approve them for you, and it sends from your Gmail.
Start free — contact these investors





